Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Andrew R Leach
Affiliation
European Bioinformatics Institute (EMBL-EBI)
ORCID
Career Start Year
1987
Papers
64
H Index
29
Expertise
CM4AI Collaborator
Kirsten Obernier (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37933841
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods.
Nucleic Acids Res
2024
37933841
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods.
Nucleic Acids Res
2024
36477213
EMBL's European Bioinformatics Institute (EMBL-EBI) in 2022.
Nucleic Acids Res
2023
37944397
Editorial overview: Restructuring drug design and development.
Curr Opin Struct Biol
2023
37749083
Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidity.
Sci Data
2023
37151295
Illuminating the druggable genome through patent bioactivity data.
PeerJ
2023
37316648
eTRANSAFE: data science to empower translational safety assessment.
Nat Rev Drug Discov
2023
36477213
EMBL's European Bioinformatics Institute (EMBL-EBI) in 2022.
Nucleic Acids Res
2023
37117846
Applications of single-cell RNA sequencing in drug discovery and development.
Nat Rev Drug Discov
2023
37429843
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure.
Nat Commun
2023
37749083
Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidity.
Sci Data
2023
37944397
Editorial overview: Restructuring drug design and development.
Curr Opin Struct Biol
2023
37316648
eTRANSAFE: data science to empower translational safety assessment.
Nat Rev Drug Discov
2023
37151295
Illuminating the druggable genome through patent bioactivity data.
PeerJ
2023
37117846
Applications of single-cell RNA sequencing in drug discovery and development.
Nat Rev Drug Discov
2023
37429843
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure.
Nat Commun
2023
34437766
The Enzyme Portal: an integrative tool for enzyme information and analysis.
FEBS J
2022
35783295
CACHE (Critical Assessment of Computational Hit-finding Experiments): A public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding.
Nat Rev Chem
2022
34437766
The Enzyme Portal: an integrative tool for enzyme information and analysis.
FEBS J
2022
35783295
CACHE (Critical Assessment of Computational Hit-finding Experiments): A public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding.
Nat Rev Chem
2022
34285415
The PROTACtable genome.
Nat Rev Drug Discov
2021
34285415
The PROTACtable genome.
Nat Rev Drug Discov
2021
33837377
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
Nat Med
2021
33618772
MAIP: a web service for predicting blood-stage malaria inhibitors.
J Cheminform
2021
33507738
Drug Safety Data Curation and Modeling in ChEMBL: Boxed Warnings and Withdrawn Drugs.
Chem Res Toxicol
2021
33983732
Target-Based Evaluation of "Drug-Like" Properties and Ligand Efficiencies.
J Med Chem
2021
34349756
Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level.
Front Immunol
2021
35211674
Target 2035 - update on the quest for a probe for every protein.
RSC Med Chem
2021
33618772
MAIP: a web service for predicting blood-stage malaria inhibitors.
J Cheminform
2021
33507738
Drug Safety Data Curation and Modeling in ChEMBL: Boxed Warnings and Withdrawn Drugs.
Chem Res Toxicol
2021
33837377
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
Nat Med
2021
35211674
Target 2035 - update on the quest for a probe for every protein.
RSC Med Chem
2021
34349756
Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level.
Front Immunol
2021
33983732
Target-Based Evaluation of "Drug-Like" Properties and Ligand Efficiencies.
J Med Chem
2021
32207937
Hotspots API: A Python Package for the Detection of Small Molecule Binding Hotspots and Application to Structure-Based Drug Design.
J Chem Inf Model
2020
32207937
Hotspots API: A Python Package for the Detection of Small Molecule Binding Hotspots and Application to Structure-Based Drug Design.
J Chem Inf Model
2020
32645325
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
Cell
2020
32627965
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens.
Mol Syst Biol
2020
32627965
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens.
Mol Syst Biol
2020
32645325
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
Cell
2020
30398643
ChEMBL: towards direct deposition of bioassay data.
Nucleic Acids Res
2019
33430932
Reply to "Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery".
J Cheminform
2019
30398643
ChEMBL: towards direct deposition of bioassay data.
Nucleic Acids Res
2019
30631996
Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery.
J Cheminform
2019
33430932
Reply to "Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery".
J Cheminform
2019
30631996
Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery.
J Cheminform
2019
29276046
Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions.
Cell Chem Biol
2018
30351302
A large-scale dataset of in vivo pharmacology assay results.
Sci Data
2018
29567993
Unexplored therapeutic opportunities in the human genome.
Nat Rev Drug Discov
2018
29472638
Unexplored therapeutic opportunities in the human genome.
Nat Rev Drug Discov
2018
1 - 50 of 128
Column Actions
Search
Recommended Authors
Sarah Barelier
CNRS, Aix-Marseille University
Career Start Year
2009
Number of shared co-authors
3
Jacob D Durrant
University of Pittsburgh
Career Start Year
2006
Number of shared co-authors
1
Sanjay J Swamidass
Washington University School of Medicine
Career Start Year
2005
Number of shared co-authors
2
Gerald H Lushington
Inc. 16 Dekalb Pike
Career Start Year
2002
Number of shared co-authors
0
Chakrapani Kalyanaraman
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year
2002
Number of shared co-authors
2
Scott Boyer
Swedish Toxicology Sciences Research Center, Karolinska Institutet
Career Start Year
2002
Number of shared co-authors
10
Heather A Carlson
University of Michigan ann arbor
Career Start Year
1999
Number of shared co-authors
2
Paul A Clemons
Broad Institute
Career Start Year
1999
Number of shared co-authors
9
Matthew P Jacobson
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year
1999
Number of shared co-authors
7
David Lagorce
INSERM
Career Start Year
1998
Number of shared co-authors
0
Eric Feyfant
Schrodinger Inc.
Career Start Year
1997
Number of shared co-authors
0
Peter Kolb
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year
1996
Number of shared co-authors
5
Andrew L Hopkins
University of Dundee
Career Start Year
1995
Number of shared co-authors
9
Hualiang Jiang
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Career Start Year
1994
Number of shared co-authors
3
Arya Ajay
National Center for Advancing Translational Science, 9800 Medical Center Drive
Career Start Year
1993
Number of shared co-authors
6
Eric Gifford
Merck Research Laboratories, Merck & Co.
Career Start Year
1991
Number of shared co-authors
0
Robert Preissner
Institute for Physiology, Charite-University Medicine Berlin
Career Start Year
1990
Number of shared co-authors
3
Howard Broughton
Lilly Research Laboratories
Career Start Year
1990
Number of shared co-authors
0
Ram Samudrala
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Career Start Year
1990
Number of shared co-authors
1
Michael S Lajiness
Lilly Research Laboratories
Career Start Year
1989
Number of shared co-authors
1
Gerhard Klebe
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year
1988
Number of shared co-authors
2
Herman W T van Vlijmen
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year
1988
Number of shared co-authors
4
Diane Joseph-McCarthy
Boston University
Career Start Year
1987
Number of shared co-authors
0
Antonio Macchiarulo
Department of Pharmaceutical Sciences, University of Perugia
Career Start Year
1986
Number of shared co-authors
1
Terry R Stouch
Lexicon Pharmaceuticals
Career Start Year
1983
Number of shared co-authors
5
Sandor Vajda
Boston University
Career Start Year
1982
Number of shared co-authors
4
Ruben Abagyan
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year
1981
Number of shared co-authors
3
Christine Humblet
Lilly Research Laboratories
Career Start Year
1977
Number of shared co-authors
4
Stephen H Bryant
National Center for Biotechnology Information
Career Start Year
1973
Number of shared co-authors
1
Jens Meiler
Vanderbilt University
Career Start Year
1954
Number of shared co-authors
5
row(s) 1 - 30 of 30
Collaborators
Anna Gaulton
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
14
Anne Hersey
Co-authored papers
11
Eloy Felix
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
8
Tudor I Oprea
Expert Systems Inc.
Co-authored papers
4
John P Overington
Institute of Cardiovascular Science, University College London
Co-authored papers
4
S??ren Brunak
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers
3
Anton Simeonov
Co-authored papers
3
George Papadatos
European Molecular Biology Laboratory - European Bioinformatics Institute
Co-authored papers
3
Brian K Shoichet
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
3
Cristian G Bologa
University of New Mexico School of Medicine
Co-authored papers
3
Gregory N Gan
Co-authored papers
2
Gergely Zahoránszky-Kſhalmi
Co-authored papers
2
Jun Qin
Co-authored papers
2
Sandra Orchard
EMBL's European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
2
Christian Reich
Co-authored papers
2
John Michael Gaziano
VA Boston Healthcare System
Co-authored papers
2
Noel Southall
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers
2
Juan P Casas
Co-authored papers
2
Suzanne Ackloo
University of Toronto
Co-authored papers
2
Ajit Jadhav
Co-authored papers
2
Jayme Holmes
Co-authored papers
2
Avi Ma'ayan
Icahn School of Medicine at Mount Sinai
Co-authored papers
2
Stephan C Sch??rer
Institute for Data Science and Computing, University of Miami
Co-authored papers
2
Oleg Ursu
Co-authored papers
2
Susumu Tomita
Co-authored papers
2
Jennifer E Huffman
Co-authored papers
2
Anneli Karlson
Co-authored papers
2
Dac-Trung Nguyen
Co-authored papers
2
Anna Waller
Co-authored papers
2
Terrence F Meehan
European Bioinformatics Institute
Co-authored papers
2
1 - 30